Cerebrolysin
Available in some countries
Description
Cerebrolysin is a mixture of neuropeptides and amino acids derived from porcine brain tissue. It is used to treat various neurological conditions, including stroke and dementia, and is being investigated for CADASIL. It may improve cognitive function and neurological outcomes.
Indications & Therapeutic Use
Stroke, Dementia, CADASIL (investigational)
Linked Diseases:
CADASIL
D046589
Global Availability (4 countries)
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Cerebrolysin
| Generic Name | Cerebrolysin |
| Drug Class | Stroke |
| Manufacturer | EVER Neuro Pharma GmbH |
| Dosage Forms | Injection |
| Medical Code | N06BX |
| Orphan Status | No |
| Cold Chain | Not Required |
| Reg. Status | Available in some countries |
| Clinical Trial | NCT00515697 |
| Countries | 4 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations5 Validated Nodes